Evidence map›Paper›PMID 42215459›Full record

ArticleNature communications2026

Native long-read RNA sequencing of human monocytes reveals activation-induced alternative splicing toward functional isoforms.

Alejandra Bodelón, Maurice J H van Haaren, Paula Sobrevals Alcaraz, Lyanne J P M Sijbers, Rianne C Scholman, Lucas W Picavet, Aafke de Ligt, Daphne van Ginneken, Remco G A Erkens, Harmjan R Vos and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Alejandra BodelónCenter for Translational Immunology, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.ORCID http://orcid.org/0000-0003-2361-8156
Maurice J H van HaarenCenter for Translational Immunology, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.ORCID http://orcid.org/0009-0001-9184-0480
Paula Sobrevals AlcarazCenter for Molecular Medicine, University Medical Center Utrecht, Oncode Institute, Utrecht, the Netherlands.
Lyanne J P M SijbersCenter for Translational Immunology, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.ORCID http://orcid.org/0009-0009-1015-164X
Rianne C ScholmanCenter for Translational Immunology, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.
Lucas W PicavetCenter for Translational Immunology, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.
Aafke de LigtCenter for Translational Immunology, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.
Daphne van GinnekenCenter for Translational Immunology, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.
Remco G A ErkensCenter for Translational Immunology, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.ORCID http://orcid.org/0000-0002-3962-7228
Harmjan R VosCenter for Molecular Medicine, University Medical Center Utrecht, Oncode Institute, Utrecht, the Netherlands.ORCID http://orcid.org/0000-0002-4696-6068
Jorg J A CalisCenter for Translational Immunology, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.
Sebastiaan J VastertCenter for Translational Immunology, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.
Jorg van LoosdregtCenter for Translational Immunology, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands. j.vanloosdregt@umcutrecht.nl.ORCID http://orcid.org/0000-0003-1411-3754

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alternative splicing is a key mechanism for expanding transcriptomic and proteomic complexity, yet its role in innate immune activation remains incompletely understood. Here, we applied Oxford Nanopore native RNA-sequencing to generate an isoform-level transcriptome of primary human monocytes before and after activation with lipopolysaccharide. We identify over 24,000 expressed isoforms, including thousands of previously unannotated variants. Activation induced widespread isoform-specific expression changes, leading to extensive isoform switching events, which were validated using matched short-read RNA-Seq. These activation-induced shifts enhanced transcript immune-regulatory functions: activated monocytes preferentially express longer, coding-competent isoforms with complete open reading frames, fewer retained introns, and increased domain complexity. By integrating matched Ribo-seq and proteomic data, we demonstrate that these isoform modulations are associated with enhanced translation of immune effector proteins. Together, our findings position alternative splicing as a dynamic and functional regulator of monocyte activation, emphasizing the need for isoform-level resolution to fully understand immune cell function.

Indexed as

Alternative SplicingMonocytesHumansImmunity, InnateLipopolysaccharidesOpen Reading FramesProtein IsoformsProteomicsSequence Analysis, RNATranscriptomeLipopolysaccharidesProtein Isoforms

Identifiers

PMID42215459
PMCPMC13392291

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.